Skip to content

Construction and application research on prevention and management strategies for intra-abdominal hypertension in children after liver transplantation

Construction and application research on prevention and management strategies for intra-abdominal hypertension in children after liver transplantation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600123318
Enrollment
Unknown
Registered
2026-04-24
Start date
2024-01-10
Completion date
Unknown
Last updated
2026-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intra-abdominal Hypertension

Interventions

Experimental group:Evidence-based prevention and management protocols and strategies for IAH in pediatric patients after liver transplantation
Routine care after liver transplantation:None

Sponsors

The First Affiliated Hospital, Zhejiang University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 3 Years

Inclusion criteria

Inclusion criteria: 1. Pediatric patients (aged <3 years) after liver transplantation; 2. The patient's family has given informed consent and voluntarily agrees to participate in this study.ments.

Exclusion criteria

Exclusion criteria: 1. Presence of contraindications to intra-abdominal pressure measurement (via bladder or stomach), 2. Low predicted post-transplant survival rate and poor prognosis, 3. Severe postoperative organ or systemic diseases (e.g., renal failure, heart failure, etc.).

Design outcomes

Primary

MeasureTime frame
Incidence of intra-abdominal hypertension;Severity of intra-abdominal hypertension;Accuracy;Incidence of abdominal compartment syndrome;

Secondary

MeasureTime frame
Duration of mechanical ventilation;Length of ICU stay;Knowledge, attitudes, and practices of nurses in the pediatric liver transplant intensive care unit regarding IAH prevention and management strategies.;

Countries

China

Contacts

Public ContactFangyan Lu

The First Affiliated Hospital, Zhejiang University School of Medicine

2196032@zju.edu.cn+86 135 0581 7318

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 7, 2026